Article: VA Study Finds Rise in 'Good' Cholesterol Cuts Risk for Heart Disease; Researchers Report Treatment of Low HDL-Cholesterol Significantly Reduces Heart Disease Death, Heart Attack, and Stroke.

MINNEAPOLIS, Aug. 4 /PRNewswire/ -- Much has been published about the health benefits of reducing high levels of "bad" low density lipoprotein (LDL) cholesterol-an overabundance of which can clog the medium and large arteries that serve the heart and brain. Now, there is definitive information to guide therapeutic decisions for heart disease patients whose primary fat abnormality is a low level of "good" high density lipoprotein (HDL) cholesterol.

In the August 5th issue of the New England Journal of Medicine, researchers with the U.S. Department of Veterans Affairs (VA) report that the drug gemfibrozil caused a six percent increase in HDL-cholesterol (relative ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!